{"slug":"hanall-biopharma","name":"한올바이오파마","name_en":"Hanall Biopharma","ticker":"009420.KS","updated_at":"2026-07-11T10:21:55.897+00:00","canonical":"https://valuechain.wiki/hanall-biopharma","kicker":"코스피 대형주","kicker_en":"KOSPI large cap","lead":"자가면역과 안과 질환 항체 신약을 개발하는 제약·바이오 기업이다. 코스피 시가총액 상위 종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A pharma developing antibody drugs for autoimmune and ophthalmic diseases. KOSPI large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"전문의약품"},{"name":"신약 개발·기술료"}]},"segments_en":{"parts":[{"name":"Prescription drugs"},{"name":"Drug development and royalties"}]},"returns_yearly":{"2021":-45.7,"2022":-6.3,"2023":88.1,"2024":32.1,"2025":26.4,"2026":11.5},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}